Medicus Pharma Ltd. Director Reports Ownership Change
Ticker: MDCX · Form: 4 · Filed: 2026-04-01T19:22:43-04:00
Sentiment: neutral
Topics: insider-transaction, ownership-change
TL;DR
Medicus Pharma director Andrew Smith changed his stock ownership on 3/30/26.
AI Summary
On March 30, 2026, Andrew Alasdair Smith, a director at Medicus Pharma Ltd., reported a change in beneficial ownership of securities. The filing details transactions related to the company's stock, but specific details on the nature of the change or the number of shares involved are not provided in this excerpt.
Why It Matters
This filing indicates a change in a director's stake in Medicus Pharma Ltd., which could signal their confidence or concerns about the company's future performance.
Risk Assessment
Risk Level: low — This is a standard Form 4 filing reporting changes in beneficial ownership, which is routine for company insiders and doesn't inherently indicate significant risk.
Key Players & Entities
- Medicus Pharma Ltd. (company) — Issuer
- Andrew Alasdair Smith (person) — Director and Reporting Person
- 0001309614 (person) — CIK for Andrew Alasdair Smith
- 0001997296 (company) — CIK for Medicus Pharma Ltd.
- 2026-03-30 (date) — Period of Report
- 2026-04-01 (date) — Filing Date
FAQ
What specific transaction(s) occurred on March 30, 2026?
The filing indicates a change in beneficial ownership of securities for Andrew Alasdair Smith on March 30, 2026, but the specific details of the transaction are not provided in the excerpt.
Who is Andrew Alasdair Smith in relation to Medicus Pharma Ltd.?
Andrew Alasdair Smith is identified as the reporting person and a director of Medicus Pharma Ltd.
What is the CIK for Medicus Pharma Ltd.?
The CIK for Medicus Pharma Ltd. is 0001997296.
What is the CIK for Andrew Alasdair Smith?
The CIK for Andrew Alasdair Smith is 0001309614.
What is the SIC code for Medicus Pharma Ltd.?
The SIC code for Medicus Pharma Ltd. is 2834, categorized under Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0000950142-26-001033 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0000950142-26-001033 Filing Date 2026-04-01 Accepted 2026-04-01 19:22:43 Documents 1 Period of Report 2026-03-30 Document Format Files Seq Description Document Type Size 1 OWNERSHIP DOCUMENT es260758781_4-smitha.html 4 1 OWNERSHIP DOCUMENT es260758781_4-smitha.xml 4 3928 Complete submission text file 0000950142-26-001033.txt 5434 Mailing Address 300 CONSHOHOCKEN STATE ROAD SUITE 200 W. CONSHOHOCKEN PA 19428 Business Address Smith Andrew Alasdair ( Reporting ) CIK : 0001309614 (see all company filings) Type: 4 | Act: 34 | File No.: 001-42408 | Film No.: 26830125 Mailing Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428 Business Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428 610-540-7515 Medicus Pharma Ltd. ( Issuer ) CIK : 0001997296 (see all company filings) EIN. : 981778211 | State of Incorp.: A6 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)